Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
25 participants
INTERVENTIONAL
2016-03-31
2019-07-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Online Memory Intervention for Individuals with Traumatic Brain Injury
NCT04331392
Written Versus Verbal Education for Mild Traumatic Brain Injury
NCT02252315
Targeted Evaluation, Action, & Monitoring of Traumatic Brain Injury
NCT02657135
Medical and Resource Facilitation Intervention After Traumatic Brain Injury
NCT03429322
Speed of Processing Training in Traumatic Brain Injury
NCT02507271
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MMPET Group
This group of subjects will be comprised of a subset of culturally diverse patients admitted to the Bellevue the Traumatic Brain Injury Unit at Bellevue. Treatment will focus on improving awareness and comprehension of TBI and its long-term consequences, fostering increased trust in the TBI rehabilitation team, and conveying the importance of continued TBI follow up to maximize recovery.
Multimedia Multicultural Educational Program for TBI (MMEPT)
Control Group
The Control Group will be comprised of equally diverse subset of patients who will receive Standard of Care Treatment.
RRTBIMS
TBI patients discharged from Bellevue inpatient rehabilitation and enrolled in the Rusk Rehabilitation Traumatic Brain Injury Model System (RRTBIMS)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
RRTBIMS
TBI patients discharged from Bellevue inpatient rehabilitation and enrolled in the Rusk Rehabilitation Traumatic Brain Injury Model System (RRTBIMS)
Multimedia Multicultural Educational Program for TBI (MMEPT)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. PTA \> 24 hours
2. Trauma related intracranial neuroimaging abnormalities
3. Loss of consciousness exceeding 30 minutes
4. GCS in emergency department of less than 13 (unless due to intubation, sedation or intoxication)
* Proficient in Chinese (Mandarin or Cantonese), Spanish or English,
* Willing to engage in the MMEPT and complete questionnaires,
* Agreeing to participate (i.e., completion of informed consent and HIPAA documents).
Exclusion Criteria
* In minimally conscious or vegetative state,
* Significant symptoms of receptive aphasia, and
* Any acute medical condition that, in the investigator's opinion, makes the person unsuitable or unable to participate. Participants enrolled in the study who are ultimately not discharged to the community at the completion of acute inpatient rehabilitation will be removed from the study.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
NYU Langone Health
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tamara Bushnik, MD
Role: PRINCIPAL_INVESTIGATOR
New York University Medical School
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
New York University School of Medicine
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
15-00356
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.